nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ALB—ulcerative colitis	0.312	1	CbGaD
Vemurafenib—ABCG2—Sulfasalazine—ulcerative colitis	0.0625	0.146	CbGbCtD
Vemurafenib—ABCG2—Hydrocortisone—ulcerative colitis	0.0501	0.117	CbGbCtD
Vemurafenib—CYP3A4—Budesonide—ulcerative colitis	0.0399	0.0929	CbGbCtD
Vemurafenib—ALB—Prednisone—ulcerative colitis	0.0344	0.0802	CbGbCtD
Vemurafenib—CYP1A2—Nicotine—ulcerative colitis	0.0331	0.0772	CbGbCtD
Vemurafenib—ABCG2—Dexamethasone—ulcerative colitis	0.0312	0.0726	CbGbCtD
Vemurafenib—CYP2D6—Nicotine—ulcerative colitis	0.0273	0.0636	CbGbCtD
Vemurafenib—CYP2D6—Cholecalciferol—ulcerative colitis	0.0245	0.057	CbGbCtD
Vemurafenib—CYP3A4—Methylprednisolone—ulcerative colitis	0.0178	0.0415	CbGbCtD
Vemurafenib—CYP3A4—Nicotine—ulcerative colitis	0.0174	0.0404	CbGbCtD
Vemurafenib—CYP3A4—Cholecalciferol—ulcerative colitis	0.0156	0.0363	CbGbCtD
Vemurafenib—CYP3A4—Triamcinolone—ulcerative colitis	0.0135	0.0314	CbGbCtD
Vemurafenib—CYP3A4—Betamethasone—ulcerative colitis	0.0116	0.027	CbGbCtD
Vemurafenib—CYP3A4—Prednisolone—ulcerative colitis	0.0114	0.0266	CbGbCtD
Vemurafenib—CYP3A4—Hydrocortisone—ulcerative colitis	0.0108	0.0252	CbGbCtD
Vemurafenib—CYP3A4—Prednisone—ulcerative colitis	0.0108	0.0251	CbGbCtD
Vemurafenib—CYP2D6—Dexamethasone—ulcerative colitis	0.0106	0.0247	CbGbCtD
Vemurafenib—CYP3A4—Dexamethasone—ulcerative colitis	0.00674	0.0157	CbGbCtD
Vemurafenib—ORM1—bile—ulcerative colitis	0.00624	0.392	CbGeAlD
Vemurafenib—Etoricoxib—PTGS2—ulcerative colitis	0.00155	1	CrCbGaD
Vemurafenib—RAF1—epithelium—ulcerative colitis	0.0013	0.0816	CbGeAlD
Vemurafenib—RAF1—smooth muscle tissue—ulcerative colitis	0.00125	0.0786	CbGeAlD
Vemurafenib—BRAF—liver—ulcerative colitis	0.0011	0.0694	CbGeAlD
Vemurafenib—RAF1—lymphoid tissue—ulcerative colitis	0.001	0.0628	CbGeAlD
Vemurafenib—RAF1—digestive system—ulcerative colitis	0.000987	0.0621	CbGeAlD
Vemurafenib—RAF1—liver—ulcerative colitis	0.000736	0.0462	CbGeAlD
Vemurafenib—ORM1—liver—ulcerative colitis	0.000508	0.0319	CbGeAlD
Vemurafenib—ALB—liver—ulcerative colitis	0.000445	0.028	CbGeAlD
Vemurafenib—CYP1A2—digestive system—ulcerative colitis	0.000393	0.0247	CbGeAlD
Vemurafenib—ABCC1—liver—ulcerative colitis	0.000368	0.0231	CbGeAlD
Vemurafenib—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000353	0.00286	CcSEcCtD
Vemurafenib—Alopecia—Mesalazine—ulcerative colitis	0.000348	0.00282	CcSEcCtD
Vemurafenib—Anaphylactic shock—Budesonide—ulcerative colitis	0.000344	0.00279	CcSEcCtD
Vemurafenib—Erythema—Mesalazine—ulcerative colitis	0.000343	0.00278	CcSEcCtD
Vemurafenib—Diarrhoea—Nicotine—ulcerative colitis	0.000342	0.00277	CcSEcCtD
Vemurafenib—Infection—Budesonide—ulcerative colitis	0.000342	0.00277	CcSEcCtD
Vemurafenib—Nervous system disorder—Budesonide—ulcerative colitis	0.000337	0.00274	CcSEcCtD
Vemurafenib—Dysgeusia—Mesalazine—ulcerative colitis	0.000336	0.00272	CcSEcCtD
Vemurafenib—Skin disorder—Budesonide—ulcerative colitis	0.000334	0.00271	CcSEcCtD
Vemurafenib—Back pain—Mesalazine—ulcerative colitis	0.000332	0.00269	CcSEcCtD
Vemurafenib—Dizziness—Nicotine—ulcerative colitis	0.00033	0.00268	CcSEcCtD
Vemurafenib—Vomiting—Mercaptopurine—ulcerative colitis	0.000328	0.00266	CcSEcCtD
Vemurafenib—Rash—Mercaptopurine—ulcerative colitis	0.000325	0.00264	CcSEcCtD
Vemurafenib—Dermatitis—Mercaptopurine—ulcerative colitis	0.000325	0.00263	CcSEcCtD
Vemurafenib—Myalgia—Azathioprine—ulcerative colitis	0.00032	0.0026	CcSEcCtD
Vemurafenib—Arthralgia—Azathioprine—ulcerative colitis	0.00032	0.0026	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000318	0.00258	CcSEcCtD
Vemurafenib—Vomiting—Nicotine—ulcerative colitis	0.000318	0.00258	CcSEcCtD
Vemurafenib—Dry skin—Dexamethasone—ulcerative colitis	0.000317	0.00257	CcSEcCtD
Vemurafenib—Dry skin—Betamethasone—ulcerative colitis	0.000317	0.00257	CcSEcCtD
Vemurafenib—Weight decreased—Hydrocortisone—ulcerative colitis	0.000316	0.00257	CcSEcCtD
Vemurafenib—Rash—Nicotine—ulcerative colitis	0.000315	0.00255	CcSEcCtD
Vemurafenib—Dermatitis—Nicotine—ulcerative colitis	0.000315	0.00255	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Budesonide—ulcerative colitis	0.000313	0.00254	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Prednisolone—ulcerative colitis	0.000313	0.00254	CcSEcCtD
Vemurafenib—Headache—Nicotine—ulcerative colitis	0.000313	0.00254	CcSEcCtD
Vemurafenib—Infestation—Hydrocortisone—ulcerative colitis	0.000312	0.00253	CcSEcCtD
Vemurafenib—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000312	0.00253	CcSEcCtD
Vemurafenib—Nausea—Mercaptopurine—ulcerative colitis	0.000306	0.00248	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Hydrocortisone—ulcerative colitis	0.000306	0.00248	CcSEcCtD
Vemurafenib—Infection—Azathioprine—ulcerative colitis	0.000305	0.00247	CcSEcCtD
Vemurafenib—ABCG2—liver—ulcerative colitis	0.000304	0.0191	CbGeAlD
Vemurafenib—Cough—Mesalazine—ulcerative colitis	0.000299	0.00243	CcSEcCtD
Vemurafenib—Decreased appetite—Budesonide—ulcerative colitis	0.000299	0.00242	CcSEcCtD
Vemurafenib—Skin disorder—Azathioprine—ulcerative colitis	0.000298	0.00242	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000297	0.00241	CcSEcCtD
Vemurafenib—Nausea—Nicotine—ulcerative colitis	0.000297	0.00241	CcSEcCtD
Vemurafenib—Fatigue—Budesonide—ulcerative colitis	0.000297	0.0024	CcSEcCtD
Vemurafenib—Constipation—Budesonide—ulcerative colitis	0.000294	0.00239	CcSEcCtD
Vemurafenib—Infestation—Methylprednisolone—ulcerative colitis	0.000293	0.00238	CcSEcCtD
Vemurafenib—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000293	0.00238	CcSEcCtD
Vemurafenib—CYP1A2—liver—ulcerative colitis	0.000293	0.0184	CbGeAlD
Vemurafenib—Arthralgia—Mesalazine—ulcerative colitis	0.000292	0.00237	CcSEcCtD
Vemurafenib—Myalgia—Mesalazine—ulcerative colitis	0.000292	0.00237	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.00029	0.00235	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Triamcinolone—ulcerative colitis	0.000288	0.00233	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Methylprednisolone—ulcerative colitis	0.000287	0.00233	CcSEcCtD
Vemurafenib—Hypotension—Azathioprine—ulcerative colitis	0.000287	0.00233	CcSEcCtD
Vemurafenib—CYP3A4—digestive system—ulcerative colitis	0.000285	0.0179	CbGeAlD
Vemurafenib—CYP2D6—digestive system—ulcerative colitis	0.00028	0.0176	CbGeAlD
Vemurafenib—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.00028	0.00227	CcSEcCtD
Vemurafenib—Anaphylactic shock—Mesalazine—ulcerative colitis	0.00028	0.00227	CcSEcCtD
Vemurafenib—Infection—Mesalazine—ulcerative colitis	0.000278	0.00225	CcSEcCtD
Vemurafenib—Dry skin—Prednisone—ulcerative colitis	0.000276	0.00224	CcSEcCtD
Vemurafenib—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000275	0.00223	CcSEcCtD
Vemurafenib—Nervous system disorder—Mesalazine—ulcerative colitis	0.000274	0.00222	CcSEcCtD
Vemurafenib—Body temperature increased—Budesonide—ulcerative colitis	0.000272	0.00221	CcSEcCtD
Vemurafenib—Skin disorder—Mesalazine—ulcerative colitis	0.000272	0.0022	CcSEcCtD
Vemurafenib—Weight decreased—Betamethasone—ulcerative colitis	0.00027	0.00219	CcSEcCtD
Vemurafenib—Weight decreased—Dexamethasone—ulcerative colitis	0.00027	0.00219	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000265	0.00215	CcSEcCtD
Vemurafenib—Eye disorder—Hydrocortisone—ulcerative colitis	0.000262	0.00212	CcSEcCtD
Vemurafenib—Hypotension—Mesalazine—ulcerative colitis	0.000261	0.00212	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Betamethasone—ulcerative colitis	0.000261	0.00212	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Dexamethasone—ulcerative colitis	0.000261	0.00212	CcSEcCtD
Vemurafenib—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000259	0.0021	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000255	0.00207	CcSEcCtD
Vemurafenib—Hypersensitivity—Budesonide—ulcerative colitis	0.000253	0.00206	CcSEcCtD
Vemurafenib—Erythema—Prednisolone—ulcerative colitis	0.00025	0.00202	CcSEcCtD
Vemurafenib—Asthenia—Budesonide—ulcerative colitis	0.000247	0.002	CcSEcCtD
Vemurafenib—Eye disorder—Methylprednisolone—ulcerative colitis	0.000246	0.00199	CcSEcCtD
Vemurafenib—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000244	0.00198	CcSEcCtD
Vemurafenib—Erythema—Hydrocortisone—ulcerative colitis	0.000244	0.00198	CcSEcCtD
Vemurafenib—Malnutrition—Hydrocortisone—ulcerative colitis	0.000244	0.00198	CcSEcCtD
Vemurafenib—Pruritus—Budesonide—ulcerative colitis	0.000243	0.00197	CcSEcCtD
Vemurafenib—Decreased appetite—Mesalazine—ulcerative colitis	0.000243	0.00197	CcSEcCtD
Vemurafenib—Body temperature increased—Azathioprine—ulcerative colitis	0.000243	0.00197	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000242	0.00196	CcSEcCtD
Vemurafenib—Fatigue—Mesalazine—ulcerative colitis	0.000241	0.00196	CcSEcCtD
Vemurafenib—Constipation—Mesalazine—ulcerative colitis	0.000239	0.00194	CcSEcCtD
Vemurafenib—Angiopathy—Methylprednisolone—ulcerative colitis	0.000239	0.00194	CcSEcCtD
Vemurafenib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000237	0.00192	CcSEcCtD
Vemurafenib—Weight decreased—Prednisone—ulcerative colitis	0.000235	0.00191	CcSEcCtD
Vemurafenib—Diarrhoea—Budesonide—ulcerative colitis	0.000235	0.00191	CcSEcCtD
Vemurafenib—Erythema—Triamcinolone—ulcerative colitis	0.00023	0.00186	CcSEcCtD
Vemurafenib—Malnutrition—Methylprednisolone—ulcerative colitis	0.000229	0.00186	CcSEcCtD
Vemurafenib—Erythema—Methylprednisolone—ulcerative colitis	0.000229	0.00186	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Prednisone—ulcerative colitis	0.000227	0.00184	CcSEcCtD
Vemurafenib—Dizziness—Budesonide—ulcerative colitis	0.000227	0.00184	CcSEcCtD
Vemurafenib—Hypersensitivity—Azathioprine—ulcerative colitis	0.000226	0.00183	CcSEcCtD
Vemurafenib—Dysgeusia—Triamcinolone—ulcerative colitis	0.000225	0.00182	CcSEcCtD
Vemurafenib—Eye disorder—Dexamethasone—ulcerative colitis	0.000224	0.00181	CcSEcCtD
Vemurafenib—Eye disorder—Betamethasone—ulcerative colitis	0.000224	0.00181	CcSEcCtD
Vemurafenib—Back pain—Triamcinolone—ulcerative colitis	0.000222	0.0018	CcSEcCtD
Vemurafenib—Body temperature increased—Mesalazine—ulcerative colitis	0.000221	0.00179	CcSEcCtD
Vemurafenib—Vomiting—Budesonide—ulcerative colitis	0.000219	0.00177	CcSEcCtD
Vemurafenib—Angiopathy—Dexamethasone—ulcerative colitis	0.000217	0.00176	CcSEcCtD
Vemurafenib—Angiopathy—Betamethasone—ulcerative colitis	0.000217	0.00176	CcSEcCtD
Vemurafenib—Rash—Budesonide—ulcerative colitis	0.000217	0.00176	CcSEcCtD
Vemurafenib—Dermatitis—Budesonide—ulcerative colitis	0.000217	0.00176	CcSEcCtD
Vemurafenib—Headache—Budesonide—ulcerative colitis	0.000215	0.00175	CcSEcCtD
Vemurafenib—CYP3A4—liver—ulcerative colitis	0.000212	0.0133	CbGeAlD
Vemurafenib—Alopecia—Betamethasone—ulcerative colitis	0.000211	0.00171	CcSEcCtD
Vemurafenib—Alopecia—Dexamethasone—ulcerative colitis	0.000211	0.00171	CcSEcCtD
Vemurafenib—Diarrhoea—Azathioprine—ulcerative colitis	0.00021	0.0017	CcSEcCtD
Vemurafenib—CYP2D6—liver—ulcerative colitis	0.000209	0.0131	CbGeAlD
Vemurafenib—Erythema—Betamethasone—ulcerative colitis	0.000208	0.00169	CcSEcCtD
Vemurafenib—Erythema—Dexamethasone—ulcerative colitis	0.000208	0.00169	CcSEcCtD
Vemurafenib—Myalgia—Hydrocortisone—ulcerative colitis	0.000208	0.00168	CcSEcCtD
Vemurafenib—Hypersensitivity—Mesalazine—ulcerative colitis	0.000206	0.00167	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000206	0.00167	CcSEcCtD
Vemurafenib—Connective tissue disorder—Prednisone—ulcerative colitis	0.000205	0.00166	CcSEcCtD
Vemurafenib—Nausea—Budesonide—ulcerative colitis	0.000204	0.00166	CcSEcCtD
Vemurafenib—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000204	0.00165	CcSEcCtD
Vemurafenib—Dizziness—Azathioprine—ulcerative colitis	0.000203	0.00165	CcSEcCtD
Vemurafenib—Asthenia—Mesalazine—ulcerative colitis	0.000201	0.00163	CcSEcCtD
Vemurafenib—Cough—Triamcinolone—ulcerative colitis	0.0002	0.00162	CcSEcCtD
Vemurafenib—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000199	0.00161	CcSEcCtD
Vemurafenib—Pruritus—Mesalazine—ulcerative colitis	0.000198	0.0016	CcSEcCtD
Vemurafenib—Infection—Hydrocortisone—ulcerative colitis	0.000198	0.0016	CcSEcCtD
Vemurafenib—Myalgia—Triamcinolone—ulcerative colitis	0.000195	0.00158	CcSEcCtD
Vemurafenib—Vomiting—Azathioprine—ulcerative colitis	0.000195	0.00158	CcSEcCtD
Vemurafenib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000195	0.00158	CcSEcCtD
Vemurafenib—Arthralgia—Methylprednisolone—ulcerative colitis	0.000195	0.00158	CcSEcCtD
Vemurafenib—Myalgia—Methylprednisolone—ulcerative colitis	0.000195	0.00158	CcSEcCtD
Vemurafenib—Eye disorder—Prednisone—ulcerative colitis	0.000195	0.00158	CcSEcCtD
Vemurafenib—Rash—Azathioprine—ulcerative colitis	0.000194	0.00157	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000194	0.00157	CcSEcCtD
Vemurafenib—Dermatitis—Azathioprine—ulcerative colitis	0.000193	0.00157	CcSEcCtD
Vemurafenib—Skin disorder—Hydrocortisone—ulcerative colitis	0.000193	0.00157	CcSEcCtD
Vemurafenib—Headache—Azathioprine—ulcerative colitis	0.000192	0.00156	CcSEcCtD
Vemurafenib—Diarrhoea—Mesalazine—ulcerative colitis	0.000191	0.00155	CcSEcCtD
Vemurafenib—Angiopathy—Prednisone—ulcerative colitis	0.000189	0.00153	CcSEcCtD
Vemurafenib—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000187	0.00152	CcSEcCtD
Vemurafenib—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000187	0.00152	CcSEcCtD
Vemurafenib—Infection—Triamcinolone—ulcerative colitis	0.000186	0.00151	CcSEcCtD
Vemurafenib—Hypotension—Hydrocortisone—ulcerative colitis	0.000186	0.00151	CcSEcCtD
Vemurafenib—Infection—Methylprednisolone—ulcerative colitis	0.000186	0.00151	CcSEcCtD
Vemurafenib—Dizziness—Mesalazine—ulcerative colitis	0.000185	0.0015	CcSEcCtD
Vemurafenib—Alopecia—Prednisone—ulcerative colitis	0.000184	0.00149	CcSEcCtD
Vemurafenib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000183	0.00149	CcSEcCtD
Vemurafenib—Nausea—Azathioprine—ulcerative colitis	0.000182	0.00148	CcSEcCtD
Vemurafenib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000182	0.00147	CcSEcCtD
Vemurafenib—Erythema—Prednisone—ulcerative colitis	0.000181	0.00147	CcSEcCtD
Vemurafenib—Malnutrition—Prednisone—ulcerative colitis	0.000181	0.00147	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000181	0.00147	CcSEcCtD
Vemurafenib—Vomiting—Mesalazine—ulcerative colitis	0.000178	0.00144	CcSEcCtD
Vemurafenib—Myalgia—Betamethasone—ulcerative colitis	0.000177	0.00144	CcSEcCtD
Vemurafenib—Myalgia—Dexamethasone—ulcerative colitis	0.000177	0.00144	CcSEcCtD
Vemurafenib—Rash—Mesalazine—ulcerative colitis	0.000176	0.00143	CcSEcCtD
Vemurafenib—Dermatitis—Mesalazine—ulcerative colitis	0.000176	0.00143	CcSEcCtD
Vemurafenib—Headache—Mesalazine—ulcerative colitis	0.000175	0.00142	CcSEcCtD
Vemurafenib—Hypotension—Methylprednisolone—ulcerative colitis	0.000175	0.00142	CcSEcCtD
Vemurafenib—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000173	0.0014	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000172	0.00139	CcSEcCtD
Vemurafenib—Fatigue—Hydrocortisone—ulcerative colitis	0.000172	0.00139	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000171	0.00138	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.00017	0.00138	CcSEcCtD
Vemurafenib—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.00017	0.00138	CcSEcCtD
Vemurafenib—Anaphylactic shock—Betamethasone—ulcerative colitis	0.00017	0.00138	CcSEcCtD
Vemurafenib—Infection—Dexamethasone—ulcerative colitis	0.000169	0.00137	CcSEcCtD
Vemurafenib—Infection—Betamethasone—ulcerative colitis	0.000169	0.00137	CcSEcCtD
Vemurafenib—Nervous system disorder—Betamethasone—ulcerative colitis	0.000167	0.00135	CcSEcCtD
Vemurafenib—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000167	0.00135	CcSEcCtD
Vemurafenib—Nausea—Mesalazine—ulcerative colitis	0.000166	0.00135	CcSEcCtD
Vemurafenib—Fatigue—Triamcinolone—ulcerative colitis	0.000161	0.00131	CcSEcCtD
Vemurafenib—Fatigue—Methylprednisolone—ulcerative colitis	0.000161	0.00131	CcSEcCtD
Vemurafenib—Hypotension—Dexamethasone—ulcerative colitis	0.000159	0.00129	CcSEcCtD
Vemurafenib—Hypotension—Betamethasone—ulcerative colitis	0.000159	0.00129	CcSEcCtD
Vemurafenib—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000157	0.00128	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000155	0.00126	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000155	0.00126	CcSEcCtD
Vemurafenib—Myalgia—Prednisone—ulcerative colitis	0.000154	0.00125	CcSEcCtD
Vemurafenib—Arthralgia—Prednisone—ulcerative colitis	0.000154	0.00125	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000153	0.00124	CcSEcCtD
Vemurafenib—Hypersensitivity—Prednisolone—ulcerative colitis	0.00015	0.00122	CcSEcCtD
Vemurafenib—Body temperature increased—Triamcinolone—ulcerative colitis	0.000148	0.0012	CcSEcCtD
Vemurafenib—Anaphylactic shock—Prednisone—ulcerative colitis	0.000148	0.0012	CcSEcCtD
Vemurafenib—Decreased appetite—Betamethasone—ulcerative colitis	0.000148	0.0012	CcSEcCtD
Vemurafenib—Decreased appetite—Dexamethasone—ulcerative colitis	0.000148	0.0012	CcSEcCtD
Vemurafenib—Infection—Prednisone—ulcerative colitis	0.000147	0.00119	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000147	0.00119	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000147	0.00119	CcSEcCtD
Vemurafenib—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000147	0.00119	CcSEcCtD
Vemurafenib—Fatigue—Dexamethasone—ulcerative colitis	0.000147	0.00119	CcSEcCtD
Vemurafenib—Fatigue—Betamethasone—ulcerative colitis	0.000147	0.00119	CcSEcCtD
Vemurafenib—Nervous system disorder—Prednisone—ulcerative colitis	0.000145	0.00118	CcSEcCtD
Vemurafenib—Skin disorder—Prednisone—ulcerative colitis	0.000144	0.00117	CcSEcCtD
Vemurafenib—Asthenia—Hydrocortisone—ulcerative colitis	0.000143	0.00116	CcSEcCtD
Vemurafenib—Pruritus—Hydrocortisone—ulcerative colitis	0.000141	0.00114	CcSEcCtD
Vemurafenib—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000138	0.00112	CcSEcCtD
Vemurafenib—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000138	0.00112	CcSEcCtD
Vemurafenib—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000136	0.0011	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000135	0.00109	CcSEcCtD
Vemurafenib—Dizziness—Prednisolone—ulcerative colitis	0.000135	0.00109	CcSEcCtD
Vemurafenib—Asthenia—Triamcinolone—ulcerative colitis	0.000134	0.00109	CcSEcCtD
Vemurafenib—Body temperature increased—Betamethasone—ulcerative colitis	0.000134	0.00109	CcSEcCtD
Vemurafenib—Body temperature increased—Dexamethasone—ulcerative colitis	0.000134	0.00109	CcSEcCtD
Vemurafenib—Asthenia—Methylprednisolone—ulcerative colitis	0.000134	0.00109	CcSEcCtD
Vemurafenib—Pruritus—Triamcinolone—ulcerative colitis	0.000133	0.00107	CcSEcCtD
Vemurafenib—Pruritus—Methylprednisolone—ulcerative colitis	0.000132	0.00107	CcSEcCtD
Vemurafenib—Dizziness—Hydrocortisone—ulcerative colitis	0.000132	0.00107	CcSEcCtD
Vemurafenib—Decreased appetite—Prednisone—ulcerative colitis	0.000129	0.00104	CcSEcCtD
Vemurafenib—Rash—Prednisolone—ulcerative colitis	0.000128	0.00104	CcSEcCtD
Vemurafenib—Dermatitis—Prednisolone—ulcerative colitis	0.000128	0.00104	CcSEcCtD
Vemurafenib—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000128	0.00104	CcSEcCtD
Vemurafenib—Fatigue—Prednisone—ulcerative colitis	0.000128	0.00103	CcSEcCtD
Vemurafenib—Headache—Prednisolone—ulcerative colitis	0.000128	0.00103	CcSEcCtD
Vemurafenib—Constipation—Prednisone—ulcerative colitis	0.000127	0.00103	CcSEcCtD
Vemurafenib—Vomiting—Hydrocortisone—ulcerative colitis	0.000126	0.00103	CcSEcCtD
Vemurafenib—Rash—Hydrocortisone—ulcerative colitis	0.000125	0.00102	CcSEcCtD
Vemurafenib—Dermatitis—Hydrocortisone—ulcerative colitis	0.000125	0.00102	CcSEcCtD
Vemurafenib—Headache—Hydrocortisone—ulcerative colitis	0.000125	0.00101	CcSEcCtD
Vemurafenib—Dizziness—Triamcinolone—ulcerative colitis	0.000124	0.001	CcSEcCtD
Vemurafenib—Dizziness—Methylprednisolone—ulcerative colitis	0.000124	0.001	CcSEcCtD
Vemurafenib—Asthenia—Dexamethasone—ulcerative colitis	0.000122	0.000989	CcSEcCtD
Vemurafenib—Asthenia—Betamethasone—ulcerative colitis	0.000122	0.000989	CcSEcCtD
Vemurafenib—Nausea—Prednisolone—ulcerative colitis	0.000121	0.000981	CcSEcCtD
Vemurafenib—Pruritus—Betamethasone—ulcerative colitis	0.00012	0.000975	CcSEcCtD
Vemurafenib—Pruritus—Dexamethasone—ulcerative colitis	0.00012	0.000975	CcSEcCtD
Vemurafenib—Vomiting—Triamcinolone—ulcerative colitis	0.000119	0.000966	CcSEcCtD
Vemurafenib—Vomiting—Methylprednisolone—ulcerative colitis	0.000119	0.000964	CcSEcCtD
Vemurafenib—Nausea—Hydrocortisone—ulcerative colitis	0.000118	0.000958	CcSEcCtD
Vemurafenib—Rash—Triamcinolone—ulcerative colitis	0.000118	0.000958	CcSEcCtD
Vemurafenib—Dermatitis—Triamcinolone—ulcerative colitis	0.000118	0.000957	CcSEcCtD
Vemurafenib—Rash—Methylprednisolone—ulcerative colitis	0.000118	0.000956	CcSEcCtD
Vemurafenib—Dermatitis—Methylprednisolone—ulcerative colitis	0.000118	0.000955	CcSEcCtD
Vemurafenib—Headache—Triamcinolone—ulcerative colitis	0.000117	0.000952	CcSEcCtD
Vemurafenib—Headache—Methylprednisolone—ulcerative colitis	0.000117	0.000949	CcSEcCtD
Vemurafenib—Body temperature increased—Prednisone—ulcerative colitis	0.000117	0.000949	CcSEcCtD
Vemurafenib—Diarrhoea—Betamethasone—ulcerative colitis	0.000116	0.000943	CcSEcCtD
Vemurafenib—Diarrhoea—Dexamethasone—ulcerative colitis	0.000116	0.000943	CcSEcCtD
Vemurafenib—Dizziness—Betamethasone—ulcerative colitis	0.000112	0.000911	CcSEcCtD
Vemurafenib—Dizziness—Dexamethasone—ulcerative colitis	0.000112	0.000911	CcSEcCtD
Vemurafenib—Nausea—Triamcinolone—ulcerative colitis	0.000111	0.000902	CcSEcCtD
Vemurafenib—Nausea—Methylprednisolone—ulcerative colitis	0.000111	0.0009	CcSEcCtD
Vemurafenib—Hypersensitivity—Prednisone—ulcerative colitis	0.000109	0.000884	CcSEcCtD
Vemurafenib—Vomiting—Dexamethasone—ulcerative colitis	0.000108	0.000876	CcSEcCtD
Vemurafenib—Vomiting—Betamethasone—ulcerative colitis	0.000108	0.000876	CcSEcCtD
Vemurafenib—Rash—Betamethasone—ulcerative colitis	0.000107	0.000869	CcSEcCtD
Vemurafenib—Rash—Dexamethasone—ulcerative colitis	0.000107	0.000869	CcSEcCtD
Vemurafenib—Dermatitis—Dexamethasone—ulcerative colitis	0.000107	0.000868	CcSEcCtD
Vemurafenib—Dermatitis—Betamethasone—ulcerative colitis	0.000107	0.000868	CcSEcCtD
Vemurafenib—Headache—Betamethasone—ulcerative colitis	0.000106	0.000863	CcSEcCtD
Vemurafenib—Headache—Dexamethasone—ulcerative colitis	0.000106	0.000863	CcSEcCtD
Vemurafenib—Asthenia—Prednisone—ulcerative colitis	0.000106	0.000861	CcSEcCtD
Vemurafenib—Pruritus—Prednisone—ulcerative colitis	0.000105	0.000849	CcSEcCtD
Vemurafenib—Diarrhoea—Prednisone—ulcerative colitis	0.000101	0.000821	CcSEcCtD
Vemurafenib—Nausea—Betamethasone—ulcerative colitis	0.000101	0.000819	CcSEcCtD
Vemurafenib—Nausea—Dexamethasone—ulcerative colitis	0.000101	0.000819	CcSEcCtD
Vemurafenib—Dizziness—Prednisone—ulcerative colitis	9.79e-05	0.000794	CcSEcCtD
Vemurafenib—Vomiting—Prednisone—ulcerative colitis	9.41e-05	0.000763	CcSEcCtD
Vemurafenib—Rash—Prednisone—ulcerative colitis	9.33e-05	0.000757	CcSEcCtD
Vemurafenib—Dermatitis—Prednisone—ulcerative colitis	9.32e-05	0.000756	CcSEcCtD
Vemurafenib—Headache—Prednisone—ulcerative colitis	9.27e-05	0.000752	CcSEcCtD
Vemurafenib—Nausea—Prednisone—ulcerative colitis	8.79e-05	0.000713	CcSEcCtD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	4.68e-05	0.000399	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—STAT3—ulcerative colitis	4.64e-05	0.000395	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	4.58e-05	0.00039	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IRF8—ulcerative colitis	4.57e-05	0.000389	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CCR6—ulcerative colitis	4.57e-05	0.000389	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	4.57e-05	0.000389	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCR2—ulcerative colitis	4.55e-05	0.000387	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	4.54e-05	0.000387	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SLC11A1—ulcerative colitis	4.46e-05	0.000379	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—ADCY5—ulcerative colitis	4.45e-05	0.000379	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SLC11A1—ulcerative colitis	4.42e-05	0.000376	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—PTGER4—ulcerative colitis	4.41e-05	0.000375	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—JAK2—ulcerative colitis	4.4e-05	0.000374	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—IL6—ulcerative colitis	4.39e-05	0.000374	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—MMP1—ulcerative colitis	4.37e-05	0.000372	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FCGR2A—ulcerative colitis	4.36e-05	0.000371	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—IL6—ulcerative colitis	4.34e-05	0.000369	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL1B—ulcerative colitis	4.33e-05	0.000368	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL2—ulcerative colitis	4.31e-05	0.000367	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	4.29e-05	0.000365	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.28e-05	0.000364	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCR6—ulcerative colitis	4.27e-05	0.000364	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	4.27e-05	0.000363	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	4.27e-05	0.000363	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.24e-05	0.000361	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—IL6—ulcerative colitis	4.2e-05	0.000357	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PTPN2—ulcerative colitis	4.18e-05	0.000356	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TP53—ulcerative colitis	4.17e-05	0.000355	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—IL6—ulcerative colitis	4.13e-05	0.000352	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	4.07e-05	0.000346	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MAML2—ulcerative colitis	4.05e-05	0.000345	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—NFKB1—ulcerative colitis	4.04e-05	0.000344	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—GHRL—ulcerative colitis	4.04e-05	0.000343	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCR1—ulcerative colitis	4.02e-05	0.000342	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MAML2—ulcerative colitis	4e-05	0.000341	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	4e-05	0.00034	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—NFKB1—ulcerative colitis	3.97e-05	0.000338	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MAML2—ulcerative colitis	3.97e-05	0.000338	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CHP1—ulcerative colitis	3.96e-05	0.000337	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—IL6—ulcerative colitis	3.95e-05	0.000336	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—IL6—ulcerative colitis	3.93e-05	0.000334	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CALM3—ulcerative colitis	3.91e-05	0.000333	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—IL6—ulcerative colitis	3.91e-05	0.000333	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CRP—ulcerative colitis	3.89e-05	0.000331	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—IL6—ulcerative colitis	3.89e-05	0.000331	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PTGER4—ulcerative colitis	3.76e-05	0.00032	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	3.76e-05	0.00032	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—PPARG—ulcerative colitis	3.76e-05	0.00032	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—TLR4—ulcerative colitis	3.73e-05	0.000318	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.73e-05	0.000317	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.71e-05	0.000315	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—CALM3—ulcerative colitis	3.67e-05	0.000312	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—IL6—ulcerative colitis	3.66e-05	0.000311	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—IL6—ulcerative colitis	3.66e-05	0.000311	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	3.66e-05	0.000311	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—MMP9—ulcerative colitis	3.63e-05	0.000309	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—STAT3—ulcerative colitis	3.63e-05	0.000309	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—IL6—ulcerative colitis	3.63e-05	0.000309	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—IL6—ulcerative colitis	3.6e-05	0.000307	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—IL6—ulcerative colitis	3.59e-05	0.000306	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—HLA-DRB1—ulcerative colitis	3.58e-05	0.000305	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—IL6—ulcerative colitis	3.58e-05	0.000305	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CALM3—ulcerative colitis	3.57e-05	0.000304	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—STAT3—ulcerative colitis	3.57e-05	0.000304	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL20—ulcerative colitis	3.53e-05	0.0003	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—RIPK2—ulcerative colitis	3.52e-05	0.000299	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CTLA4—ulcerative colitis	3.47e-05	0.000295	CbGpPWpGaD
Vemurafenib—BRAF—Disease—ADCY5—ulcerative colitis	3.46e-05	0.000294	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—GHRL—ulcerative colitis	3.45e-05	0.000293	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	3.44e-05	0.000293	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—ICAM1—ulcerative colitis	3.44e-05	0.000292	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—DLD—ulcerative colitis	3.41e-05	0.000291	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—ADRB2—ulcerative colitis	3.34e-05	0.000284	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CALM3—ulcerative colitis	3.34e-05	0.000284	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.33e-05	0.000283	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GNA12—ulcerative colitis	3.32e-05	0.000282	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—ALB—ulcerative colitis	3.31e-05	0.000282	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD79A—ulcerative colitis	3.31e-05	0.000281	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CALM3—ulcerative colitis	3.3e-05	0.000281	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—RIPK2—ulcerative colitis	3.29e-05	0.00028	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CALM3—ulcerative colitis	3.27e-05	0.000278	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CHP1—ulcerative colitis	3.27e-05	0.000278	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	3.24e-05	0.000276	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	3.22e-05	0.000274	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—NOD2—ulcerative colitis	3.19e-05	0.000271	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD14—ulcerative colitis	3.17e-05	0.00027	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCR2—ulcerative colitis	3.15e-05	0.000268	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—JAK2—ulcerative colitis	3.14e-05	0.000267	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	3.13e-05	0.000267	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—JAK2—ulcerative colitis	3.08e-05	0.000262	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—VCAM1—ulcerative colitis	3.06e-05	0.00026	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-DQA1—ulcerative colitis	3.05e-05	0.00026	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—RELA—ulcerative colitis	3.04e-05	0.000259	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTGS1—ulcerative colitis	3.04e-05	0.000259	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CDH1—ulcerative colitis	3.04e-05	0.000258	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.99e-05	0.000254	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCR6—ulcerative colitis	2.96e-05	0.000252	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.87e-05	0.000244	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ADRB2—ulcerative colitis	2.85e-05	0.000243	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.84e-05	0.000242	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—ADCY5—ulcerative colitis	2.84e-05	0.000241	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—DLD—ulcerative colitis	2.82e-05	0.00024	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	2.81e-05	0.000239	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MAML2—ulcerative colitis	2.8e-05	0.000239	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—JAK2—ulcerative colitis	2.77e-05	0.000236	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CHP1—ulcerative colitis	2.77e-05	0.000235	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CALM3—ulcerative colitis	2.74e-05	0.000233	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—IL2—ulcerative colitis	2.69e-05	0.000229	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—RELA—ulcerative colitis	2.69e-05	0.000229	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTGS1—ulcerative colitis	2.68e-05	0.000228	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CD4—ulcerative colitis	2.63e-05	0.000224	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.62e-05	0.000223	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PTGER4—ulcerative colitis	2.6e-05	0.000222	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.59e-05	0.000221	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—MMP9—ulcerative colitis	2.59e-05	0.000221	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ADCY5—ulcerative colitis	2.59e-05	0.00022	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—RELA—ulcerative colitis	2.58e-05	0.000219	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—NFKB1—ulcerative colitis	2.56e-05	0.000218	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL6—ulcerative colitis	2.54e-05	0.000216	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD4—ulcerative colitis	2.52e-05	0.000215	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.5e-05	0.000213	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—IL6—ulcerative colitis	2.49e-05	0.000212	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.47e-05	0.00021	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ADCY5—ulcerative colitis	2.42e-05	0.000206	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CALM3—ulcerative colitis	2.41e-05	0.000205	CbGpPWpGaD
Vemurafenib—RAF1—Disease—ADCY5—ulcerative colitis	2.39e-05	0.000204	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—DLD—ulcerative colitis	2.39e-05	0.000203	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GHRL—ulcerative colitis	2.38e-05	0.000203	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—ADCY5—ulcerative colitis	2.37e-05	0.000202	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—MMP1—ulcerative colitis	2.35e-05	0.0002	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CALM3—ulcerative colitis	2.31e-05	0.000196	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—STAT3—ulcerative colitis	2.3e-05	0.000196	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.3e-05	0.000196	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RIPK2—ulcerative colitis	2.27e-05	0.000194	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CRP—ulcerative colitis	2.27e-05	0.000193	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—NFKB1—ulcerative colitis	2.26e-05	0.000193	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—IL6—ulcerative colitis	2.26e-05	0.000192	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.19e-05	0.000186	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—NFKB1—ulcerative colitis	2.17e-05	0.000185	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TLR4—ulcerative colitis	2.17e-05	0.000185	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-DRB1—ulcerative colitis	2.17e-05	0.000185	CbGpPWpGaD
Vemurafenib—BRAF—Disease—JAK2—ulcerative colitis	2.16e-05	0.000183	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TGFB1—ulcerative colitis	2.14e-05	0.000182	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CHP1—ulcerative colitis	2.14e-05	0.000182	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ABCB1—ulcerative colitis	2.13e-05	0.000181	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TGFB1—ulcerative colitis	2.1e-05	0.000178	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ICAM1—ulcerative colitis	2.08e-05	0.000177	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CD4—ulcerative colitis	2.04e-05	0.000174	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PTGS2—ulcerative colitis	2.03e-05	0.000173	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TNF—ulcerative colitis	1.99e-05	0.00017	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ADCY5—ulcerative colitis	1.99e-05	0.000169	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ADRB2—ulcerative colitis	1.97e-05	0.000168	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ABCB1—ulcerative colitis	1.87e-05	0.000159	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—DLD—ulcerative colitis	1.84e-05	0.000157	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CDH1—ulcerative colitis	1.84e-05	0.000157	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.81e-05	0.000154	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—JAK2—ulcerative colitis	1.77e-05	0.00015	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ADCY5—ulcerative colitis	1.75e-05	0.000149	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TP53—ulcerative colitis	1.73e-05	0.000147	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ADCY5—ulcerative colitis	1.68e-05	0.000143	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—JAK2—ulcerative colitis	1.66e-05	0.000141	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTGS1—ulcerative colitis	1.65e-05	0.00014	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—JAK2—ulcerative colitis	1.62e-05	0.000137	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCL8—ulcerative colitis	1.61e-05	0.000137	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—IL6—ulcerative colitis	1.61e-05	0.000137	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IFNG—ulcerative colitis	1.59e-05	0.000135	CbGpPWpGaD
Vemurafenib—BRAF—Disease—STAT3—ulcerative colitis	1.58e-05	0.000135	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—RELA—ulcerative colitis	1.56e-05	0.000133	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL2—ulcerative colitis	1.54e-05	0.000131	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD4—ulcerative colitis	1.53e-05	0.00013	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—JAK2—ulcerative colitis	1.51e-05	0.000128	CbGpPWpGaD
Vemurafenib—RAF1—Disease—JAK2—ulcerative colitis	1.49e-05	0.000127	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CALM3—ulcerative colitis	1.49e-05	0.000126	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PPARG—ulcerative colitis	1.48e-05	0.000126	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—JAK2—ulcerative colitis	1.48e-05	0.000126	CbGpPWpGaD
Vemurafenib—BRAF—Disease—TGFB1—ulcerative colitis	1.47e-05	0.000125	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—RELA—ulcerative colitis	1.46e-05	0.000124	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IL2—ulcerative colitis	1.45e-05	0.000123	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—IL6—ulcerative colitis	1.42e-05	0.000121	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.42e-05	0.000121	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL1B—ulcerative colitis	1.41e-05	0.00012	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD4—ulcerative colitis	1.41e-05	0.00012	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL2—ulcerative colitis	1.41e-05	0.00012	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PTGS2—ulcerative colitis	1.4e-05	0.000119	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD4—ulcerative colitis	1.4e-05	0.000119	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PTGS2—ulcerative colitis	1.39e-05	0.000118	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCL8—ulcerative colitis	1.38e-05	0.000117	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTGS1—ulcerative colitis	1.36e-05	0.000116	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ALB—ulcerative colitis	1.33e-05	0.000113	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—NFKB1—ulcerative colitis	1.32e-05	0.000112	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL2—ulcerative colitis	1.32e-05	0.000112	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PPARG—ulcerative colitis	1.3e-05	0.000111	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.26e-05	0.000107	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MMP9—ulcerative colitis	1.25e-05	0.000106	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NFKB1—ulcerative colitis	1.23e-05	0.000105	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CALM3—ulcerative colitis	1.23e-05	0.000104	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—STAT3—ulcerative colitis	1.19e-05	0.000101	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ALB—ulcerative colitis	1.17e-05	9.97e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTGS2—ulcerative colitis	1.16e-05	9.91e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ABCB1—ulcerative colitis	1.16e-05	9.84e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTGS1—ulcerative colitis	1.15e-05	9.83e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.14e-05	9.66e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TGFB1—ulcerative colitis	1.13e-05	9.6e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—STAT3—ulcerative colitis	1.11e-05	9.43e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—IL6—ulcerative colitis	1.11e-05	9.4e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—STAT3—ulcerative colitis	1.09e-05	9.31e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—STAT3—ulcerative colitis	1.08e-05	9.23e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADCY5—ulcerative colitis	1.08e-05	9.18e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—JAK2—ulcerative colitis	1.04e-05	8.89e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CALM3—ulcerative colitis	1.04e-05	8.85e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TGFB1—ulcerative colitis	1.03e-05	8.74e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTGS2—ulcerative colitis	1.03e-05	8.72e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TGFB1—ulcerative colitis	1.01e-05	8.63e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RELA—ulcerative colitis	1.01e-05	8.61e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TGFB1—ulcerative colitis	1.01e-05	8.56e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.93e-06	8.45e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ABCB1—ulcerative colitis	9.54e-06	8.12e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL8—ulcerative colitis	9.53e-06	8.11e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TP53—ulcerative colitis	9.29e-06	7.9e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL2—ulcerative colitis	9.11e-06	7.75e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL6—ulcerative colitis	9.06e-06	7.71e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	8.91e-06	7.58e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADCY5—ulcerative colitis	8.9e-06	7.58e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MMP9—ulcerative colitis	8.62e-06	7.34e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NFKB1—ulcerative colitis	8.53e-06	7.26e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TP53—ulcerative colitis	8.45e-06	7.19e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL6—ulcerative colitis	8.28e-06	7.05e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ABCB1—ulcerative colitis	8.08e-06	6.88e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARG—ulcerative colitis	8.04e-06	6.84e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CALM3—ulcerative colitis	8.02e-06	6.83e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL6—ulcerative colitis	7.74e-06	6.59e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—STAT3—ulcerative colitis	7.66e-06	6.52e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IL6—ulcerative colitis	7.65e-06	6.51e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IL6—ulcerative colitis	7.58e-06	6.45e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADCY5—ulcerative colitis	7.54e-06	6.42e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TGFB1—ulcerative colitis	7.1e-06	6.05e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARG—ulcerative colitis	6.64e-06	5.65e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTGS2—ulcerative colitis	6.33e-06	5.38e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	6.24e-06	5.31e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALB—ulcerative colitis	5.97e-06	5.08e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TP53—ulcerative colitis	5.85e-06	4.98e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	5.82e-06	4.95e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARG—ulcerative colitis	5.62e-06	4.79e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL6—ulcerative colitis	5.35e-06	4.56e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTGS2—ulcerative colitis	5.22e-06	4.44e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALB—ulcerative colitis	5.06e-06	4.3e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTGS2—ulcerative colitis	4.42e-06	3.77e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARG—ulcerative colitis	4.34e-06	3.69e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALB—ulcerative colitis	3.9e-06	3.32e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	3.41e-06	2.91e-05	CbGpPWpGaD
